Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Tripti, Khare"'
Autor:
Alexei J. Stuckel, Shuai Zeng, Zhen Lyu, Wei Zhang, Xu Zhang, Urszula Dougherty, Reba Mustafi, Tripti Khare, Qiong Zhang, Trupti Joshi, Marc Bissonnette, Sharad Khare
Publikováno v:
Epigenetics, Vol 18, Iss 1 (2023)
Sprouty4 (SPRY4) has been frequently reported as a tumor suppressor and is therefore downregulated in various cancers. For the first time, we report that SPRY4 is epigenetically upregulated in colorectal cancer (CRC). In this study, we explored DNA m
Externí odkaz:
https://doaj.org/article/01f8717e29a94b0eaa5128dbd992adb5
Publikováno v:
Epigenetics, Vol 17, Iss 13, Pp 2318-2331 (2022)
CXCR4 is involved in many facets of cancer, including being a major player in establishing metastasis. This is in part due to the deregulation of CXCR4, which can be attributed to many genetic and epigenetic mechanisms, including aberrant microRNA–
Externí odkaz:
https://doaj.org/article/ee2dbae64af94adf8ad00e06d8e14eb6
Publikováno v:
Biomolecules, Vol 12, Iss 5, p 645 (2022)
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. HCC is diagnosed in its advanced stage when limited treatment options are available. Substantial morphologic, genetic and epigenetic heterogeneity has been
Externí odkaz:
https://doaj.org/article/05272bcf6fde430fa2826b9eab08ba97
Autor:
Alexei J, Stuckel, Shuai, Zeng, Zhen, Lyu, Wei, Zhang, Xu, Zhang, Urszula, Dougherty, Reba, Mustafi, Tripti, Khare, Qiong, Zhang, Trupti, Joshi, Marc, Bissonnette, Sharad, Khare
Publikováno v:
Epigenetics. 18
Sprouty4 (SPRY4) has been frequently reported as a tumor suppressor and is therefore downregulated in various cancers. For the first time, we report that SPRY4 is epigenetically upregulated in colorectal cancer (CRC). In this study, we explored DNA m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18686006396d6a88389bafb81cd3f7b3
https://doi.org/10.1080/15592294.2022.2145068
https://doi.org/10.1080/15592294.2022.2145068
Publikováno v:
International Journal of Biological Macromolecules. 165:722-737
Treatments for inflammatory bowel disease (IBD) are typically immunosuppressive. Despite a range of treatment options, limited efficacy, systemic toxicities like bone marrow suppression, infections and malignancy are their serious setbacks. There exi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e15d009104f8f20e8d31245a7747118
https://doi.org/10.1016/j.ijbiomac.2020.09.214
https://doi.org/10.1016/j.ijbiomac.2020.09.214
Autor:
Tripti Khare, Carol S. Giometti
Publikováno v:
BioTechniques, Vol 40, Iss 5, Pp 584-588 (2006)
Externí odkaz:
https://doaj.org/article/7b93ae2ccaa840b3906d92c95f1bb100
Autor:
Xu Zhang, Urszula Dougherty, Wei Zhang, Diana C. West-Szymanski, Shuai Zeng, Qiong Zhang, Tripti Khare, Trupti Joshi, Alexei J. Stuckel, Reba Mustafi, Elsa Perreand, Marc Bissonnette, Sharad Khare
Publikováno v:
Cancers, Vol 12, Iss 3104, p 3104 (2020)
Cancers
Cancers
In colorectal cancer (CRC), upregulation of the C-X-C motif chemokine receptor 4 (CXCR4) is correlated with metastasis and poor prognosis, highlighting the need to further elucidate CXCR4’s regulation in CRC. For the first time, DNA methylation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431a7e434eb3bcce3949edfdf66b4876
https://www.mdpi.com/2072-6694/12/11/3104
https://www.mdpi.com/2072-6694/12/11/3104
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 3956, p 3956 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 3956, p 3956 (2020)
Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory Bowel Disease (IBD). However, they all are implicated in causing severe side effects and long-term use results in many complications. Numerous in vitro and in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024a53a247482ee6b485af3d0e479e99
https://pubmed.ncbi.nlm.nih.gov/32486445
https://pubmed.ncbi.nlm.nih.gov/32486445
Autor:
Shuai Zeng, Tripti Khare, Trupti Joshi, Wei Zhang, Alexei J. Stuckel, Qiong Zhang, Marc Bissonnette, Diana C. West-Szymanski, Elsa Perreand, Urszula Dougherty, Reba Mustafi, Xu Zhang, Sharad Khare
Publikováno v:
Cancers, Vol 12, Iss 3, p 539 (2020)
Cancers
Volume 12
Issue 3
Cancers
Volume 12
Issue 3
In colorectal cancer (CRC), upregulation of the C-X-C motif chemokine receptor 4 (CXCR4) is correlated with metastasis and poor prognosis, highlighting the need to further elucidate CXCR4&rsquo
s regulation in CRC. For the first time, DNA methyl
s regulation in CRC. For the first time, DNA methyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f140ba811d4fa0fb7dd76c4d588d745
https://www.mdpi.com/2072-6694/12/3/539
https://www.mdpi.com/2072-6694/12/3/539
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7371, p 7371 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 7371, p 7371 (2021)
Chemokines are chemotactic cytokines that promote cancer growth, metastasis, and regulate resistance to chemotherapy. Stromal cell-derived factor 1 (SDF1) also known as C-X-C motif chemokine 12 (CXCL12), a prognostic factor, is an extracellular homeo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6605adaeea8778fe2935e89579296165
https://doi.org/10.3390/ijms22147371
https://doi.org/10.3390/ijms22147371